Literature DB >> 6180177

Specifically unmethylated cytidylic-guanylate sites in Herpesvirus saimiri DNA in tumor cells.

R C Desrosiers.   

Abstract

The restriction endonucleases MspI (CCGG), HpaII (CCGG), FnuDII (CGCG), and HaeIII (GGCC) were used to study the methylation of Herpesvirus saimiri DNA in tumor cells taken directly from tumor-bearing animals. No evidence was found for methylation of the 5' terminal C in the sequence CCGG or of the internal C in the sequence GGCC, but extensive methylation of CG was detected. Fifteen HpaII sites and 17 FnuDII sites were detected in the unique DNA region of the H. saimiri strain used. Twenty-eight of the 32 sites were methylated in greater than 90% of the viral DNA molecules in tumor cells, but the remaining 4 sites were unmethylated in greater than 95% of the viral DNA molecules in tumor cells. The locations of the four specifically unmethylated sites were mapped and appeared to be identical in the four different induced leukemias examined (one owl monkey and three white-lipped marmosets). The nonproducer 1670 tumor cell line, in continuous passage for over 7 years, contained four similar specifically unmethylated sites. Possibilities for the physiological significance of the unmethylated sites are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180177      PMCID: PMC256145     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Morphology of a disease with features of malignant lymphoma in marmosets and owl monkeys inoculated with Herpesvirus saimiri.

Authors:  R D Hunt; L V Meléndez; N W King; C E Gilmore; M D Daniel; M E Williamson; T C Jones
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Epstein-Barr virus RNA in Burkitt tumor tissue.

Authors:  T Dambaugh; F K Nkrumah; R J Biggar; E Kieff
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome.

Authors:  G W Bornkamm; H Delius; B Fleckenstein; F J Werner; C Mulder
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

5.  Demonstration of Herpesvirus saimiri-associated antigens in peripheral lymphocytes from infected marmosets during in vitro cultivation.

Authors:  L A Falk; L G Wolfe; J Hoekstra; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

6.  Transplantation and cytogenetic studies of Herpesvirus saimiri-induced disease in Marmoset monkeys.

Authors:  B Marczynska; L Falk; L Wolfe; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

7.  Altering genotype and phenotype by DNA-mediated gene transfer.

Authors:  A Pellicer; D Robins; B Wold; R Sweet; J Jackson; I Lowy; J M Roberts; G K Sim; S Silverstein; R Axel
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

8.  Direct detection of methylated cytosine in DNA by use of the restriction enzyme MspI.

Authors:  H Cedar; A Solage; G Glaser; A Razin
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

9.  Episomal viral DNA in a Herpesvirus saimiri-transformed lymphoid cell line.

Authors:  F J Werner; G W Bornkamm; B Fleckenstein
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

10.  The presence of Herpesvirus Saimiri genomes in virus-transformed cells.

Authors:  B Fleckenstein; I Müller; J Werner
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

View more
  12 in total

1.  Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri.

Authors:  J M Koomey; C Mulder; R L Burghoff; B Fleckenstein; R C Desrosiers
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

2.  Expression of the hepatitis B virus genome in chronic hepatitis B carriers and patients with hepatocellular carcinoma.

Authors:  S M Bowyer; G M Dusheiko; B D Schoub; M C Kew
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Effects of S-adenosylhomocysteine and analogs on Epstein-Barr virus-induced transformation, expression of the Epstein-Barr virus capsid antigen, and methylation of Epstein-Barr virus DNA.

Authors:  W K Long; G E Fronko; R G Lindemeyer; B Wu; E E Henderson
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

4.  Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation.

Authors:  S Schirm; I Müller; R C Desrosiers; B Fleckenstein
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Transformation of owl monkey T cells in vitro with Herpesvirus saimiri.

Authors:  H Rabin; R F Hopkins; R C Desrosiers; J R Ortaldo; J Y Djeu; R H Neubauer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Structure of nonintegrated, circular Herpesvirus saimiri and Herpesvirus ateles genomes in tumor cell lines and in vitro-transformed cells.

Authors:  C Kaschka-Dierich; F J Werner; I Bauer; B Fleckenstein
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

7.  Human placental DNA methyltransferase: DNA substrate and DNA binding specificity.

Authors:  R Y Wang; L H Huang; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1984-04-25       Impact factor: 16.971

8.  Primary structure of the herpesvirus saimiri genome.

Authors:  J C Albrecht; J Nicholas; D Biller; K R Cameron; B Biesinger; C Newman; S Wittmann; M A Craxton; H Coleman; B Fleckenstein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 9.  Eukaryotic DNA methylation.

Authors:  D N Cooper
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  Construction of replication-competent Herpesvirus saimiri deletion mutants.

Authors:  R C Desrosiers; R L Burghoff; A Bakker; J Kamine
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.